HPE vs ZBIO · P/E 20, rev $32.19B vs rev $10.0M
Hewlett Packard Enterprise Co (HPE) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Hewlett Packard Enterprise Co (HPE) is a communication equipment company listed on US.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported HPE revenue for 2026-07-31 was $32.19B. Net income was $2.62B. Revenue was up 61.1% from 2026-04-30 to 2026-07-31. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
HPE currently screens at market cap $27.19B and trailing P/E 19.9. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the HPE and ZBIO stock pages for the full models.
Not investment advice.